Evidence map›Paper›PMID 36655119›Full record

ArticleClinical and translational radiation oncology2023

Oxygen-enhanced MRI and radiotherapy in patients with oropharyngeal squamous cell carcinoma.

Emma Bluemke, Ambre Bertrand, Kwun-Ye Chu, Nigar Syed, Andrew G Murchison, Rosie Cooke, Tessa Greenhalgh, Brian Burns, Martin Craig, Nia Taylor and 3 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Oxygen-Enhanced MRI Detects Incidence, Onset, and Heterogeneity of Radiation-Induced Hypoxia Modification in HPV-Associated Oropharyngeal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  6. Review
  7. Observational
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Emma BluemkeInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, UK.
Ambre BertrandInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, UK.
Kwun-Ye ChuMRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, UK.
Nigar SyedMRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, UK.
Andrew G MurchisonDepartment of Radiology, Oxford University Hospitals NHS Foundation Trust, UK.
Rosie CookeMRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, UK.
Tessa GreenhalghMRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, UK.
Brian BurnsGE Healthcare CA, USA.
Martin CraigUniversity of Nottingham, UK.
Nia TaylorDepartment of Radiology, Oxford University Hospitals NHS Foundation Trust, UK.
Ketan ShahMRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, UK.
Fergus GleesonDepartment of Radiology, Oxford University Hospitals NHS Foundation Trust, UK.
Daniel BulteInstitute of Biomedical Engineering, Department of Engineering Science, University of Oxford, UK.
University of Oxford · GBOxford University Hospitals NHS Trust · GBUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: This study aimed to assess the role of T1 mapping and oxygen-enhanced MRI in patients undergoing radical dose radiotherapy for HPV positive oropharyngeal cancer, which has not yet been examined in an OE-MRI study. Materials and methods: Variable Flip Angle T1 maps were acquired on a 3T MRI scanner while patients (n = 12) breathed air and/or 100 % oxygen, before and after fraction 10 of the planned 30 fractions of chemoradiotherapy ('visit 1' and 'visit 2', respectively). The analysis aimed to assess to what extent (1) native R1 relates to patient outcome; (2) OE-MRI response relates to patient outcome; (3) changes in mean R1 before and after radiotherapy related to clinical outcome in patients with oropharyngeal squamous cell carcinoma. Results: Due to the radiotherapy being largely successful, the sample sizes of non-responder groups were small, and therefore it was not possible to properly assess the predictive nature of OE-MRI. The tumour R1 increased in some patients while decreasing in others, in a pattern that was overall consistent with the underlying OE-MRI theory and previously reported tumour OE-MRI responses. In addition, we discuss some practical challenges faced when integrating this technique into a clinical trial, with the aim that sharing this is helpful to researchers planning to use OE-MRI in future clinical studies. Conclusion: Altogether, these results suggest that further clinical OE-MRI studies to assess hypoxia and radiotherapy response are worth pursuing, and that there is important work to be done to improve the robustness of the OE-MRI technique in human applications in order for it to be useful as a widespread clinical technique.

Indexed as

HypoxiaMRIOropharyngeal squamous cell carcinomaOxygenOxygen-enhanced MRI

Identifiers

PMID36655119
PMCPMC9841018
OpenAlexW4311905976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.